This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS Aug. 16, 2011
ASCLS eNewsBytes
Aug. 16, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


Antibody cocktail promises safer stem cell therapy
New Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Fears that stem cell therapies could seed a bizarre form of tumors may be calmed by a cocktail of antibodies. Because human embryonic stem cells can develop into any type of cell, they hold great promise in the field of regenerative medicine, which aims to replace cells or tissues lost to injury or disease. But their broad developmental capacity could also be their undoing. More



Study: Breast cancer drug raises risk of heart problems in older women
HealthDay via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The breast cancer drug Herceptin increases the risk of heart problems in elderly patients, especially those with a history of heart disease and/or diabetes, a new study says. Researchers analyzed the medical records of 45 women who were treated with Herceptin and found that 26.7 percent of them developed heart problems caused by the drug. More

Bayer anti-clot drug gets cautious journal welcome
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An anti-clotting pill from Bayer and Johnson & Johnson offers a new way of preventing stroke, although further studies will be needed to refine treatment options, according to a review in a top medical journal. The editorial in the New England Journal of Medicine will be read closely by doctors and industry analysts, who have been grappling with results from a difficult-to-interpret clinical trial of Xarelto. More

STA Coag ConneXion

STA Coag ConneXion is an easy to use, Windows 7 based user interface that offers comprehensive QC management, remote QC capability and standardized result reporting with the use of expert rules for auto validation. For more information on STA Coag ConnneXion, visit www.stago-us.com.


Man with breast cancer denied Medicaid coverage because he's not a woman
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For Raymond Johnson it was bad enough being diagnosed with cancer when he was just 26 and with no health insurance, but his shock was only aggravated when he was denied Medicaid, because rules say men are not covered for breast cancer. Johnson, a construction worker from Charleston, S.C., is one of the roughly 2,000 men who develop breast cancer each year — just 1 percent of all breast cancer cases. More

Study: Hope on leukemia
Worcester Telegram & Gazette    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study published in New England Journal of Medicine offers startling and hopeful news for those afflicted by the most common form of leukemia. Using gene therapy, scientists appear to have cleared the disease — for a year and counting — from three men with advanced cases of chronic lymphocytic leukemia. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.
MORE


New treatment option for prostate cancer
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Prostate cancer that has become resistant to hormone treatment and that does not respond to radiation or chemotherapy requires new methods of treatment. By attacking stem cell-like cells in prostate cancer, researchers are working on a project to develop a new treatment option. More

Study: Blood tests tied to anemia in heart attack patients
Reuters via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Drawing blood for medical tests could make sick patients even sicker, hints a new study that suggests taking blood for testing, over and over, may not be as innocent as doctors used to think. Earlier research has shown that as many as half of heart attack patients who arrive at the hospital with normal levels of red blood cells go home with anemia, a deficit of the oxygen-carrying red cells, often serious enough to cause symptoms. More



At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or www.phadia.us.


Fetal DNA in mom's blood predicts baby's sex
MedPage Today via ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Testing for fetal DNA in a pregnant woman's blood can accurately predict the child's sex, researchers have found. In a review of previous research, such tests were able to accurately pin down sex at least 95 percent of the time, Stephanie Devaney of the National Institutes of Health in Bethesda, Md., and colleagues reported in the Journal of the American Medical Association. More

Looking for a Vitamin D Control?

Fujirebio Diagnostics, Inc. introduces an assayed, tri-level Vitamin D Control containing clinically relevant levels of Vitamin D. This control includes 25(OH)Vitamin D2 and 25(OH)Vitamin D3. MORE
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Aug. 9, 2011
  • Aug. 2, 2011
  • July 26, 2011
  • July 19, 2011
  • July 12, 2011
  •  RSS Feed
    Most popular articles